Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC

Kinase domain duplications of the epidermal growth factor receptor (EGFR‐KDD) have been identified and implicated to be oncogenic in nonsmall cell lung cancers (NSCLCs). However, its prevalence and clinical contributions in lung cancer are largely unknown. Here, we conducted a multicenter record rev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Principais autores: Wang, Jinguang, Li, Xingya, Xue, Xingyang, Ou, Qiuxiang, Wu, Xue, Liang, Ying, Wang, Xiaonan, You, Ming, Shao, Yang W., Zhang, Zhihong, Zhang, Shucai
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Cancer Genetics and Epigenetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590137/
https://ncbi.nlm.nih.gov/pubmed/30255937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31895
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados